Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells

Tumor Biology

Volumn 34, Issue 2, 2013, Pages 875-885

  Park, Byeong Bae ^a   Yoon, Jin Sun ^a   Kim, Eun Shil ^a   Choi, Jiyoung ^a   Won, Young Woong ^a   Choi, Jung Hye ^a   Lee, Young Yiul ^a  

^a Hanyang University   (South Korea)

Author keywords

Eupatilin; Gastric cancer; Growth inhibition; Invasion; Metastasis

Indexed keywords

6 AMINOQUINAZOLINE; BETA CATENIN; CASPASE 3; EUPATILIN; GELATINASE A; GELATINASE B; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; PROTEIN P42; PROTEIN P44; QUINAZOLINE DERIVATIVE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; FLAVONOID; HERBACEOUS AGENT; MESSENGER RNA; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

APOPTOSIS; ARTEMISIA; ARTEMISIA ASIATICA; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MKN 1; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TREATMENT RESPONSE; TUMOR INVASION; ZYMOGRAPHY; CANCER INVASION; CELL MOTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CASPASE 3; CELL MOVEMENT; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; HUMANS; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 84877152685     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0621-y     Document Type: Article

References (36)

1. Maehara Y, Kakeji Y, Oda S, Baba H, Sugimachi K. Tumor growth patterns and biological characteristics of early gastric carcinoma. Oncology. 2001;61:102-12.
2. Schwartz GK. Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations. Semin Oncol. 1996;23:316-24.
3. Tahara E. Molecular aspects of invasion and metastasis of stomach cancer. Verhandlungen der Deutschen Gesellschaft fur Pathologie. 2000;84:43-9.
4. Inumaru J, Nagano O, Takahashi E, Ishimoto T, Nakamura S, Suzuki Y, et al. Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells. 2009;14:703-16.
5. Satoh J, Kuroda Y. Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors. Neuropathology. 2000;20:113-23.
6. Hiendlmeyer E, Regus S, Wassermann S, Hlubek F, Haynl A, Dimmler A. Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res. 2004;64:1209-14.
7. Kundu JK, Choi KY, Surh YJ. beta-Catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances. Biochim Biophys Acta. 2006;1765:14-24.
8. Qin H, Moellinger JD, Wells A, Windsor LJ, Sun Y, Benveniste EN. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J Immunol. 1998;161:6664-73.
9. Shellman YG, Makela M, Norris DA. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res. 2006;16:207-11.
10. Yano S, Nokihara H, Yamamoto A. Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci. 2003;94:244-52.
11. Zhang XY, Chan WY, Whitney BM. Changes of interleukin expression correlate with Helicobacter pylori infection and lymph node metastases in gastric carcinoma. Diagn Mol Pathol. 2003;11:135-9.
12. Shun CT, Lin JT, Huang SP, Lin MT, Wu MS. Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas. World J Gastroenterol. 2005;11:3767-71.
13. Uemura N, Okamoto S, Yamamoto S. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
14. Yonemura Y, Sakurai S, Yamamoto H. REG gene expression is associated with the infiltrating growth of gastric carcinoma. Cancer. 2003;98:1394-400.
15. Eck M, Schmausser B, Scheller K. CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol. 2000;122:192-9.
16. Hritz I, Kuester D, Vieth M. Secretory leukocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2006;18:277-82.
17. Lee HY, Park KS, Kim MK. A small compound that inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 upregulation. Biochem Biophys Res Commun. 2005;336:716-22.
18. Hagemann T, Wilson J, Kulbe H. Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol. 2005;175:1197-205.
19. Woo ER, Pokharel YR, Yang JW, Lee SY, Kang KW. Inhibition of nuclear factor-kappaB activation by 2′,8″-biapigenin. Biol Pharm Bull. 2006;29:976-80.
20. Lee JS, Kim HS, Hahm KB. Inhibitory effects of 7-carboxymethyloxy- 3′,4′,5-trimethoxyflavone (DA-6034) on Helicobacter pylori-induced NF-kappa B activation and iNOS expression in AGS cells. Ann N Y Acad Sci. 2007;1095:527-35.
21. Shukla S, Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes. Clin Cancer Res. 2004;10:3169-78.
22. Kim DH, Na HK, Oh TY, Shin CY, Surh YJ. Eupatilin inhibits proliferation of ras-transformed human breast epithelial (MCF-10A-ras) cells. J Environ Pathol Toxicol Oncol. 2005;24:251-9.
23. Kim MJ, Kim DH, Na HK, Oh TY, Shin CY, Surh YJ. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces apoptosis in human gastric cancer (AGS) cells. J Environ Pathol Toxicol Oncol. 2005;24:261-9.
24. Kim DH, Na HK, Oh TY, Kim WB, Surh YJ. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells. Biochem Pharmacol. 2004;68:1081-7.
25. Yang WL, Godwin AK, Xu XX. Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk. Cancer Res. 2004;64:1534-40.
26. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha. Exp Cell Res. 1996;223:395-404.
27. Foda HD, Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today. 2001;6:478-82.
28. Ossowski L, Aguirre-Ghiso JA. Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol. 2000;12:613-20.
29. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV. Regulation of integrin function by the urokinase receptor. Science. 1996;273:1551-5.
30. Mei JM, Borchert GL, Donald SP, Phang JM. Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis. 2002;23:2119-22.
31. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A. 2000;97:4262-6.
32. Maupas-Schwalm F, Robinet C, Auge N, Thiers JC, Garcia V, Cambus JP. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Cancer Res. 2005;65:526-32.
33. Moreau M, Mourah S, Dosquet C. beta-Catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells. Int J Cancer. 2011;128:1280-92.
34. Dianne CD, Zhong C, Gang D, Frank GO, Jeffery SW, Keith B, Ulrich S, Carter VW. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression and tumor growth in vivo. Cancer Res. 1999;59:3468-74.
35. Sethi G, Ahn KS, Pandey MK, Aggarwal BB. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppress invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 2007;109:2727-2735.
36. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol Suppl. 1996;215:3-10.